Risks

IMCC’s very high net debt to EBITDA and negative interest coverage versus profitable cannabis peers increase refinancing and dilution risk if capital markets tighten.

Current and quick ratios below 1.0 versus stronger-liquidity peers leave less room to absorb working-capital swings, pressuring operations and supplier confidence.

Days sales outstanding above 180 days versus faster-collecting peers indicate slower cash realization, which can constrain inventory funding and near-term growth execution.

Debt to equity above 4.0 versus lower-levered peers raises balance-sheet fragility, making IMCC more exposed to margin compression and covenant stress in a weak pricing environment.

Opportunities

If Canadian and international cannabis demand continues to normalize, IMCC’s operating leverage could improve faster than smaller peers with less scale and weaker distribution reach.

Longer payables than receivables can support near-term liquidity versus peers, giving IMCC some working-capital flexibility while industry pricing remains volatile.

Any easing in sector financing conditions would disproportionately help IMCC versus more levered peers because its capital structure leaves greater room for valuation recovery.

If wholesale and branded product mix improves, IMCC could capture margin upside versus commodity-heavy peers that remain more exposed to price compression.

Overall Score

IMCC’s forward positioning is constrained mainly by leverage, weak liquidity, and slow cash collection, while only modest upside exists from sector normalization and working-capital flexibility.